Submitting risk management plans draft guidance document: Opioid products
Opioid products need to include specific content within their RMP to address: the risk and uncertainties of opioid-related harms in Canada and other risks and uncertainties posed by the product, where warranted.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Submitting risk management plans draft guidance document: Opioid productsHTMLEnglish publication HTML
-
Submitting risk management plans draft guidance document: Opioid productsHTMLFrench publication HTML
Similar records